Moreover, to better assess the source of CPS-induced ROS generation, BC cells were treated with CPS alone or in combination with the mitochondrial respiratory chain inhibitor rotenone (ROT, 1 μM) or the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI, 0.1 μM). The gene discussed is FMO5; the disease is breast cancer.